期刊文献+

长双歧杆菌发酵培养基的优化 被引量:3

Optimizing fermentation medium of Bifidobacterium longum
原文传递
导出
摘要 目的对长双歧杆菌液态发酵培养基进行优化。方法以长双歧杆菌(Bifidobacterium longum)为发酵菌株,以MRS培养基为基础培养基,以发酵液活菌数为指标,通过单因素添加实验考察发酵培养基的碳源和氮源的种类,并验证优化后培养基的效果。结果优化后培养基的最适碳源为葡萄糖,最适氮源为酪蛋白胨、牛肉蛋白胨、水解乳蛋白,发酵液活菌数达到2.09×109CFU/mL,比原MRS培养基(1.22×109CFU/mL)提高了71.30%。结论优化后培养基优于原MRS基础培养基,可应用于长双歧杆菌的液态发酵。 Objective To optimize liquid fermentation medium of Bifidobacterium longum. Methods MRS was used as the basic medium; viable count in fermentation broth was used as the evaluation index. Single factor test was performed to investigate the carbon and nitrogen sources and verify the optimized medium. Results The best carbon source of optimized culture medium was glucose, and the best nitrogen sources were casein peptone, beef peptone and lactalbumin hydrolysate. The viable bacterial count reached 2.09 ×109 CFU/mL, increased by 71.3% compared to original MRS ( 1.22 × 109 CFU/mL). Conclusion The optimized medium is superior to bas- al medium, and applicable to the Bifidobacterium longum.
出处 《中国微生态学杂志》 CAS CSCD 2014年第3期253-257,共5页 Chinese Journal of Microecology
基金 内蒙古医科大学青年创新基金(qncx2012024) 内蒙古自治区自然科学基金项目(2011MS1211)
关键词 长双歧杆菌 培养基优化 正交试验 Bifidobacterium longum Optimizing fermentation medium Orthogonal design
  • 相关文献

参考文献7

二级参考文献31

  • 1徐志毅.肠道正常菌群与人体的关系[J].微生物学通报,2005,32(3):117-120. 被引量:23
  • 2别明江,刘祥,潘素华,王波,余倩.糖尿病模型小鼠的肠道菌群与血糖关系的探讨[J].现代预防医学,2005,32(11):1441-1443. 被引量:20
  • 3李岩.抗生素相关性腹泻[J].中国实用内科杂志,2007,27(13):1012-1013. 被引量:75
  • 4Barlett JG. Clinical practice. Antibiotic-associated diarrhea[J].N Engl J Med,2002,346(5) :334-339.
  • 5McFarland LV. Epidemiology,risk factors and treatments for antibiotic- associated diarrhea[J]. Dig Dis, 1998,16(5) :292-307.
  • 6Hurley BW, Nguyen CC. The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea[J]. Arch Intern Med,2002,162(19) : 2177-2184.
  • 7Cloud CV,McDonald LC. Bench-to-bedside review:Clostridium difficile colitis[J]. Crit Care ,2008,12( 1 ) :203.
  • 8Wenisch C, Parschalk B, Hasenhundl M, et al. Comparison of vancomyein, teicoplanin,metronidazole,and fusidic acid for the treatment of Clostri- dium difficile-associated diarrhea[J]. Clin Infect Dis, 1996,22(5) :813- 818.
  • 9Cloud J,Kelly CP. Update on Clostridium difficile associated disease[J]. Curr Opin Gastroenterol, 2007,23 ( 1 ) : 4-9.
  • 10Gagnon M,Kheadr EE,Le Blay G,et al. In vitro inhibition of Escherichia coli 01 57 : H7 by bifidobacterial strains of human origin[J]. Int J Food Mierobiol, 2004,92 ( 1 ) : 69- 78.

共引文献44

同被引文献33

引证文献3

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部